Emad Behboudi
Research Subjects
Research Interests
Emad Behboudi has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
- Javad Charostad
Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran
4 shared publications - Mohsen Nakhaie
Research Center of Tropical and Infectious Diseases Kerman University of Medical Sciences Kerman Iran
4 shared publications - Nasir Arefinia
School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran
4 shared publications - Abdolvahab Moradi
Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
3 shared publications - Alireza Tahamtan
Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
3 shared publications Bahman Aghcheli
Gonabad University of Medical Sciences
3 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (20)
Association of IFN ‐γ +874 T/A Polymorphism With COVID ‐19 Susceptibility, Severity, and Inflammatory Response: A Case–Control Study From Southern Iran
Background: Significant interpatient variability in Coronavirus Disease 2019 (COVID‐19) manifestations highlights the influence of host genetic factors on disease outcomes. This study examines its association with COVID‐19 susceptibility, severity, and inflammatory markers in an Iranian population. Methods: A retrospective case–control analysis was performed on 210 COVID‐19 patients and 210 age‐ and sex‐matched control subjects to evaluate whether the Interferon‐gamma (IFN‐γ) gene polymorphism (+874 T/A) is associated with disease severity. Results: Patients had more comorbidities (e.g., diabetes 26.2% vs. 14.3%; hypertension 29.5% vs. 16.7%) and pronounced paraclinical abnormalities, including elevated Neutrophil‐to‐Lymphocyte Ratio (NLR) (8.1 vs. 1.9), C‐reactive protein (CRP) (45.5 vs. 3.2 mg/L), and lymphopenia (1.1 vs. 2.1 × 10 3 /μL; all p < 0.001). The TA genotype and A allele increased disease susceptibility (Odds Ratio (OR) =2.05 (95% CI: 1.32–3.19), p = 0.002; OR = 1.58 (95% CI: 1.11–2.25), p = 0.01, respectively). The TA genotype independently predicted severe disease (aOR = 2.85, p = 0.001), and both the TA and AA genotypes were linked to higher IL‐6 levels ( p < 0.001). TT carriers had shorter hospitalizations ( p < 0.01). Combining TA/AA with NLR improved severity prediction (AUC = 0.82 (95% CI: 0.76–0.88)). Conclusion: The IFN‐γ +874 TA genotype was independently associated with severe COVID‐19. The TA genotype appears to confer increased risk of severe disease, whereas the AA genotype may be linked to a milder clinical presentation despite elevated inflammatory markers. Integration of genetic and hematological parameters may enhance risk stratification; however, further validation in larger and diverse populations is warranted.
- 23 September 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (20)
Open AccessAssociation of IFN ‐γ +874 T/A Polymorphism With COVID ‐19 Susceptibility, Severity, and Inflammatory Response: A Case–Control Study From Southern Iran
Background: Significant interpatient variability in Coronavirus Disease 2019 (COVID‐19) manifestations highlights the influence of host genetic factors on disease outcomes. This study examines its association with COVID‐19 susceptibility, severity, and inflammatory markers in an Iranian population. Methods: A retrospective case–control analysis was performed on 210 COVID‐19 patients and 210 age‐ and sex‐matched control subjects to evaluate whether the Interferon‐gamma (IFN‐γ) gene polymorphism (+874 T/A) is associated with disease severity. Results: Patients had more comorbidities (e.g., diabetes 26.2% vs. 14.3%; hypertension 29.5% vs. 16.7%) and pronounced paraclinical abnormalities, including elevated Neutrophil‐to‐Lymphocyte Ratio (NLR) (8.1 vs. 1.9), C‐reactive protein (CRP) (45.5 vs. 3.2 mg/L), and lymphopenia (1.1 vs. 2.1 × 10 3 /μL; all p < 0.001). The TA genotype and A allele increased disease susceptibility (Odds Ratio (OR) =2.05 (95% CI: 1.32–3.19), p = 0.002; OR = 1.58 (95% CI: 1.11–2.25), p = 0.01, respectively). The TA genotype independently predicted severe disease (aOR = 2.85, p = 0.001), and both the TA and AA genotypes were linked to higher IL‐6 levels ( p < 0.001). TT carriers had shorter hospitalizations ( p < 0.01). Combining TA/AA with NLR improved severity prediction (AUC = 0.82 (95% CI: 0.76–0.88)). Conclusion: The IFN‐γ +874 TA genotype was independently associated with severe COVID‐19. The TA genotype appears to confer increased risk of severe disease, whereas the AA genotype may be linked to a milder clinical presentation despite elevated inflammatory markers. Integration of genetic and hematological parameters may enhance risk stratification; however, further validation in larger and diverse populations is warranted.
- Open Access
- 1 August 2026
- Published by InkVista Publishing House
- Vol. 25 (4) , 623-625
Dengue fever outbreak in Iran: Urgent warnings and solutions
Dear Editor, Following the COVID-19 pandemic, dengue fever, one of the most important mosquito-borne viral diseases, has become a serious public health challenge in many countries around the world in recent years. Transmitted by Aedes aegypti and Aedes albopictus mosquitoes, this disease is prevalent in tropical and subtropical regions. Iran is ...
- 1 August 2026
- Published by InkVista Publishing House
- Vol. 25 (4) , 623-625
Open AccessDengue fever outbreak in Iran: Urgent warnings and solutions
Dear Editor, Following the COVID-19 pandemic, dengue fever, one of the most important mosquito-borne viral diseases, has become a serious public health challenge in many countries around the world in recent years. Transmitted by Aedes aegypti and Aedes albopictus mosquitoes, this disease is prevalent in tropical and subtropical regions. Iran is ...
- Open Access
- 22 May 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Cytokine gene polymorphisms and susceptibility to chronic hepatitis B virus infection in familial clusters from Iran: a cross-sectional study
This study investigated the associations between specific polymorphisms in the Interleukin-10 (IL-10), Interleukin-18 (IL-18), Interleukin-1 beta (IL-1^
- 22 May 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessCytokine gene polymorphisms and susceptibility to chronic hepatitis B virus infection in familial clusters from Iran: a cross-sectional study
This study investigated the associations between specific polymorphisms in the Interleukin-10 (IL-10), Interleukin-18 (IL-18), Interleukin-1 beta (IL-1^
- Open Access
- 3 March 2026
- Published by SAGE Publications in European Journal of Inflammation
- Vol. 24
The role of platelet in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with manifestations ranging from mild skin symptoms to severe organ and neurological involvement. Thrombosis is a major complication and leading cause of mortality, though its mechanisms remain unclear. Emerging evidence highlights platelets, beyond their hemostatic role, as central players in SLE pathogenesis. This narrative review summarizes platelet-driven pathways in SLE, emphasizing their roles in thrombosis and immune regulation. Platelets interact with immune complexes, complement, and infectious agents, triggering activation and the release of mediators and microparticles. These processes increase circulating autoantigens and promote both thrombosis and autoimmune responses. Understanding these non-hemostatic platelet functions offers new insight into SLE mechanisms and may guide future platelet-targeted therapies.
- 3 March 2026
- Published by SAGE Publications in European Journal of Inflammation
- Vol. 24
Open AccessThe role of platelet in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with manifestations ranging from mild skin symptoms to severe organ and neurological involvement. Thrombosis is a major complication and leading cause of mortality, though its mechanisms remain unclear. Emerging evidence highlights platelets, beyond their hemostatic role, as central players in SLE pathogenesis. This narrative review summarizes platelet-driven pathways in SLE, emphasizing their roles in thrombosis and immune regulation. Platelets interact with immune complexes, complement, and infectious agents, triggering activation and the release of mediators and microparticles. These processes increase circulating autoantigens and promote both thrombosis and autoimmune responses. Understanding these non-hemostatic platelet functions offers new insight into SLE mechanisms and may guide future platelet-targeted therapies.
- Open Access
- 24 February 2026
- Published by SAGE Publications in European Journal of Inflammation
- Vol. 24
COVID-19 pathogenesis: Immune dynamics, inflammatory cascades, and therapeutic frontiers
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has posed unprecedented challenges to global health. Understanding the complex molecular and cellular mechanisms underlying SARS-CoV-2 infection is critical for developing effective therapeutic strategies. This narrative review comprehensively examines the key pathogenesis pathways involved in SARS-CoV-2 infection, with a focus on viral entry mechanisms, innate and adaptive immune responses, and the dysregulated inflammatory cascades that drive disease severity. We highlight the pivotal roles of immune cells, such as neutrophils, macrophages, natural killer cells, and T lymphocyte subsets, in orchestrating both protective and pathological responses. Central to severe COVID-19 is the excessive release of pro-inflammatory cytokines, known as the cytokine storm, which leads to acute respiratory distress syndrome and multi-organ failure. Furthermore, we critically evaluate conflicting evidence regarding key immunopathological processes. We further explore the impact of viral variants on immune evasion and therapeutic efficacy, as well as the emerging biomarkers that may guide personalized treatment. Finally, we discuss current and prospective therapeutic interventions, analyzing the clinical evidence and limitations of strategies targeting viral replication, immune modulation, and inflammation resolution. This synthesis provides valuable insights into the pathophysiology of COVID-19 and underscores the importance of integrated, adaptive approaches to combat this evolving disease.
- 24 February 2026
- Published by SAGE Publications in European Journal of Inflammation
- Vol. 24
Open AccessCOVID-19 pathogenesis: Immune dynamics, inflammatory cascades, and therapeutic frontiers
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has posed unprecedented challenges to global health. Understanding the complex molecular and cellular mechanisms underlying SARS-CoV-2 infection is critical for developing effective therapeutic strategies. This narrative review comprehensively examines the key pathogenesis pathways involved in SARS-CoV-2 infection, with a focus on viral entry mechanisms, innate and adaptive immune responses, and the dysregulated inflammatory cascades that drive disease severity. We highlight the pivotal roles of immune cells, such as neutrophils, macrophages, natural killer cells, and T lymphocyte subsets, in orchestrating both protective and pathological responses. Central to severe COVID-19 is the excessive release of pro-inflammatory cytokines, known as the cytokine storm, which leads to acute respiratory distress syndrome and multi-organ failure. Furthermore, we critically evaluate conflicting evidence regarding key immunopathological processes. We further explore the impact of viral variants on immune evasion and therapeutic efficacy, as well as the emerging biomarkers that may guide personalized treatment. Finally, we discuss current and prospective therapeutic interventions, analyzing the clinical evidence and limitations of strategies targeting viral replication, immune modulation, and inflammation resolution. This synthesis provides valuable insights into the pathophysiology of COVID-19 and underscores the importance of integrated, adaptive approaches to combat this evolving disease.
- Open Access
- 21 October 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Frequency of complementary medicine use and attitudes among Iranian patients with chronic diseases
The study aimed to determine the frequency of the use of complementary medicine (CM) in patients with chronic diseases and its relationship with their attitude towards CM. This cross-sectional study was conducted in Sina Hospital, a general clinical setting located in Tabriz city, Northwest Iran. A total of 400 adult patients with chronic diseases—including cardiac, rheumatologic, endocrine, and nephrological conditions—were recruited using convenience sampling from both specialized outpatient clinics and a traditional medicine unit. Data collection involved structured interviews conducted in clinical settings. Descriptive statistics and bivariate tests were performed, followed by binary logistic regression analysis to identify predictors of CM modality use. According to the result, the most commonly used complementary and alternative Medicine within the past 12 months were Herbal Medicine, Prayer Therapy, Water therapy, Cupping and Massage Therapy with 83, 36, 27, 11, and 8%, respectively. The mean scores of the patients’ attitude towards holistic health were higher than their attitude towards the validity of complementary medicine (21.37 vs. 15.88). Logistic regression analysis revealed that belief in holistic health significantly predicted lower odds of using herbal medicine (OR = 0.85, p = .005), prayer therapy (OR = 0.85, p = .018), and water therapy (OR = 0.82, p = .009). Belief in CM’s scientific validity was positively associated with prayer therapy use (OR = 1.24, p < .001). Additional predictors varied by modality: increased age and high economic status predicted greater use of prayer and water therapies, whereas gender and education levels showed mixed associations. The use of herbal medicine was common among patients with chronic diseases. Therefore, health care providers should pay attention to the use of herbal medicine by their patients considering their interactions with modern medications, efficacy, and side effects. Given the poor attitude towards the validity of CM, there is a need for community-level education on the use of CM for prescribing it by professional practitioners.
- 21 October 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Open AccessFrequency of complementary medicine use and attitudes among Iranian patients with chronic diseases
The study aimed to determine the frequency of the use of complementary medicine (CM) in patients with chronic diseases and its relationship with their attitude towards CM. This cross-sectional study was conducted in Sina Hospital, a general clinical setting located in Tabriz city, Northwest Iran. A total of 400 adult patients with chronic diseases—including cardiac, rheumatologic, endocrine, and nephrological conditions—were recruited using convenience sampling from both specialized outpatient clinics and a traditional medicine unit. Data collection involved structured interviews conducted in clinical settings. Descriptive statistics and bivariate tests were performed, followed by binary logistic regression analysis to identify predictors of CM modality use. According to the result, the most commonly used complementary and alternative Medicine within the past 12 months were Herbal Medicine, Prayer Therapy, Water therapy, Cupping and Massage Therapy with 83, 36, 27, 11, and 8%, respectively. The mean scores of the patients’ attitude towards holistic health were higher than their attitude towards the validity of complementary medicine (21.37 vs. 15.88). Logistic regression analysis revealed that belief in holistic health significantly predicted lower odds of using herbal medicine (OR = 0.85, p = .005), prayer therapy (OR = 0.85, p = .018), and water therapy (OR = 0.82, p = .009). Belief in CM’s scientific validity was positively associated with prayer therapy use (OR = 1.24, p < .001). Additional predictors varied by modality: increased age and high economic status predicted greater use of prayer and water therapies, whereas gender and education levels showed mixed associations. The use of herbal medicine was common among patients with chronic diseases. Therefore, health care providers should pay attention to the use of herbal medicine by their patients considering their interactions with modern medications, efficacy, and side effects. Given the poor attitude towards the validity of CM, there is a need for community-level education on the use of CM for prescribing it by professional practitioners.
- Open Access
- 1 January 2025
- Published by Wiley in Advances in Virology
- Vol. 2025 (1) , 5750575
The Interplay Between Viral Infection and Cell Death: A Ping‐Pong Effect
Programmed cell death (PCD) is a well‐studied cellular mechanism that plays a critical role in immune responses, developmental processes, and the maintenance of tissue homeostasis. However, viruses have developed diverse strategies to bypass or manipulate the host apoptotic machinery to enhance their replication and survival. As a result, the interaction between PCD pathways and viruses has garnered increased interest, leading to many studies being published in recent years. This study aims to provide an overview of the current understanding of PCD pathways and their significance in viral infections. We will discuss various forms of cell death pathways, including apoptosis, autophagy, necroptosis, and pyroptosis, as well as their corresponding molecular mechanisms. In addition, we will show how viruses manipulate host PCD pathways to prevent or delay cell death or facilitate viral replication. This study emphasizes the importance of investigating the mechanisms by which viruses control the host’s PCD machinery to gain insight into the evolutionary dynamics of host‐pathogen interactions and to develop new approaches for predicting and managing viral threats. Overall, we aimed to highlight new research areas in PCD and viruses, including introduction of new targets for the development of new antiviral drugs to modulate the cellular apoptotic machinery and novel inhibitors of host cell death pathways.
- 1 January 2025
- Published by Wiley in Advances in Virology
- Vol. 2025 (1) , 5750575
Open AccessThe Interplay Between Viral Infection and Cell Death: A Ping‐Pong Effect
Programmed cell death (PCD) is a well‐studied cellular mechanism that plays a critical role in immune responses, developmental processes, and the maintenance of tissue homeostasis. However, viruses have developed diverse strategies to bypass or manipulate the host apoptotic machinery to enhance their replication and survival. As a result, the interaction between PCD pathways and viruses has garnered increased interest, leading to many studies being published in recent years. This study aims to provide an overview of the current understanding of PCD pathways and their significance in viral infections. We will discuss various forms of cell death pathways, including apoptosis, autophagy, necroptosis, and pyroptosis, as well as their corresponding molecular mechanisms. In addition, we will show how viruses manipulate host PCD pathways to prevent or delay cell death or facilitate viral replication. This study emphasizes the importance of investigating the mechanisms by which viruses control the host’s PCD machinery to gain insight into the evolutionary dynamics of host‐pathogen interactions and to develop new approaches for predicting and managing viral threats. Overall, we aimed to highlight new research areas in PCD and viruses, including introduction of new targets for the development of new antiviral drugs to modulate the cellular apoptotic machinery and novel inhibitors of host cell death pathways.
- 25 November 2024
- Published by Academic World Research in Razi Journal of Medical Sciences
- Vol. 31 (1) , 1-6
Mitigating the Risk: Tackling Viral Infections in Dentistry
Viral infections pose a significant risk to both dental professionals and patients, and it is crucial that we address this concern. Firstly, the close proximity between dental professionals and patients during dental procedures increases the likelihood of viral transmission. Dental practitioners may be exposed to a wide range of viruses in the ...
- 25 November 2024
- Published by Academic World Research in Razi Journal of Medical Sciences
- Vol. 31 (1) , 1-6
Mitigating the Risk: Tackling Viral Infections in Dentistry
Viral infections pose a significant risk to both dental professionals and patients, and it is crucial that we address this concern. Firstly, the close proximity between dental professionals and patients during dental procedures increases the likelihood of viral transmission. Dental practitioners may be exposed to a wide range of viruses in the ...
- Open Access
- 20 November 2024
- Published by LIDSEN Publishing Inc in OBM Genetics
- Vol. 08 (04) , 1-25
Epstein-Barr Virus and Helicobacter pylori as Two Main Risk Factors in Gastric Cancer
Microbial and viral pathogens have emerged as key contributors to cancer development. Research conducted in the last twenty years has significantly enhanced our comprehension of the cancer-causing capabilities of infectious agents. An illustrative instance is gastric cancer (GC), which is closely associated with Helicobacter pylori (H. pylori) and Epstein-Barr virus (EBV) infections, with approximately 90% of non-cardia GC cases attributed to H. pylori infection and around 10% linked to EBV. Despite significant research efforts, GC remains a severe clinical challenge, ranking as the fifth most commonly diagnosed cancer worldwide. In 2020, an estimated 768,793 people died from GC in the world. The pathogenicity island (PAI), cagA protein, VacA, and other virulence factors in H. pylori and several latency factors such as EBNA-1, LMP-1, and LMP2A in Epstein-Barr virus, as well as pattern of gene methylation and EBV and H. pylori co-infection are shown as the leading causes of pathogen-related GC. The unique molecular and clinical characteristics associated with EBV and H. pylori in GC highlight the importance of further understanding their respective roles in GC development and progression. This knowledge may inform future preventive and therapeutic strategies targeting these infectious agents in the context of GC. This review aims to elucidate the mechanisms underpinning GC's EBV and H. pylori-induced carcinogenesis.
- 20 November 2024
- Published by LIDSEN Publishing Inc in OBM Genetics
- Vol. 08 (04) , 1-25
Open AccessEpstein-Barr Virus and Helicobacter pylori as Two Main Risk Factors in Gastric Cancer
Microbial and viral pathogens have emerged as key contributors to cancer development. Research conducted in the last twenty years has significantly enhanced our comprehension of the cancer-causing capabilities of infectious agents. An illustrative instance is gastric cancer (GC), which is closely associated with Helicobacter pylori (H. pylori) and Epstein-Barr virus (EBV) infections, with approximately 90% of non-cardia GC cases attributed to H. pylori infection and around 10% linked to EBV. Despite significant research efforts, GC remains a severe clinical challenge, ranking as the fifth most commonly diagnosed cancer worldwide. In 2020, an estimated 768,793 people died from GC in the world. The pathogenicity island (PAI), cagA protein, VacA, and other virulence factors in H. pylori and several latency factors such as EBNA-1, LMP-1, and LMP2A in Epstein-Barr virus, as well as pattern of gene methylation and EBV and H. pylori co-infection are shown as the leading causes of pathogen-related GC. The unique molecular and clinical characteristics associated with EBV and H. pylori in GC highlight the importance of further understanding their respective roles in GC development and progression. This knowledge may inform future preventive and therapeutic strategies targeting these infectious agents in the context of GC. This review aims to elucidate the mechanisms underpinning GC's EBV and H. pylori-induced carcinogenesis.
- Open Access
- 18 August 2024
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 18 (3) , 148-162
JNK Signaling Pathways and Oncoviruses
Oncoviruses utilize the host cell signaling pathways. The role of the host cellular kinases as the main signaling factors in the viral replication and assembly has been reported before. The c-Jun NH2-terminal kinases (JNKs) as members of the mitogen-activated protein kinase (MAPK) family are stress-activated protein kinases that can be triggered by ...
- 18 August 2024
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 18 (3) , 148-162
Open AccessJNK Signaling Pathways and Oncoviruses
Oncoviruses utilize the host cell signaling pathways. The role of the host cellular kinases as the main signaling factors in the viral replication and assembly has been reported before. The c-Jun NH2-terminal kinases (JNKs) as members of the mitogen-activated protein kinase (MAPK) family are stress-activated protein kinases that can be triggered by ...